Events Search and Views Navigation
June 2019
Noble Life Sciences will be attending Diversity Alliance For Science 2019 East Coast Conference, a very interactive meeting where corporations and small and/or divers businesses build relationships to drive inclusive procurement practices. Noble is proud to be graduating from 2018 – 2019 mentorship program and feel fortunate to be mentored by Eli Lilly. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. With our capabilities spanning from small to large animals, flow cytometry, live animal [...]
Find out moreSeptember 2019
Noble Life Sciences is proud to be a Hosting Partner, Exhibitor of CAR-TCR Summit 2019. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. We offer a wide variety of cell line derived xenograft (CDX) and syngeneic models, CAR-T models, subcutaneous, orthotopic and disseminated models, and GvHD models to support oncology and immune-oncology therapeutic development. Noble has conducted over 100 CAR-T projects and with our capabilities spanning from small to large animals, flow cytometry, live [...]
Find out moreNovember 2019
Noble Life Sciences is Exhibiting at ACT 2019, 40th Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 503 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace. Stay tuned, we will be updating this page with more information as we get closer to the meeting.
Find out moreFebruary 2020
Visit us at Booth #31 IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
Find out moreMarch 2020
Noble Life Sciences is Exhibiting at SOT 2020, 59th Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 213 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace.
Find out moreApril 2020
R&D + Strategic Partnering For The Global Vaccine Industry Visit us at Booth #1
Find out moreMay 2020
The Symposium on Advanced Wound Care Spring | Wound Healing Society (SAWC Spring | WHS) meeting features exciting new cutting-edge topics led by the most dynamic and influential educators in wound healing. Be a part of the movement and join your global community of difference makers at SAWC who are committed to providing better care and better outcomes. Visit us at Booth #105
Find out moreThe 41st Annual Meeting will include a wide-ranging scientific program, a welcome reception, the popular poster session reception, an awards ceremony and luncheon, distinguished plenary speakers, and numerous professional networking events.
Find out moreSeptember 2020
World Vaccine Congress Washington, the world's most exciting vaccine event is coming to you virtually. Noble Life Sciences is exhibiting at World Vaccine Congress Washington 2020, September 28 – October 1, 2020. Noble Life Sciences is a preclinical CRO validated portfolio of preclinical in vitro assays and in vivo disease models in infectious diseases and immunology to support preclinical development. Connect with us to discuss your preclinical vaccine development needs. Schedule a meeting to learn how Noble can support to accelerate and de-risk your vaccine development.
Find out moreOctober 2020
Noble Life Sciences in partnership with NorthEast BioLab is hosting a webinar. Overview: The need for expedited drug development and efficient capital allocation has placed a justified emphasis on early in vivo testing for pharmacology and disease modulation. In this webinar, we would share actionable insights from our 100+ years of collective experience managing drug discovery, pharmacokinetics (PK), and biomarker testing studies. Agenda: Drug discovery screening process from target selectivity to potency in preclinical disease models In vivo proof-of-concept PK and Biomarker testing towards clinical efficacy based on drug exposure and biological response In vitro ADME (protein binding, [...]
Find out more
